Catalyst
Slingshot members are tracking this event:
PTC Therapeutics (PTCT) Set for $20MM Milestone After Roche (RHHBY) Initiates Phase 2 SUNFISH Trial Evaluating RG7916 in Pediatric and Adult Patients with Type 2/3 Spinal Muscular Atrophy (SMA)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTCT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 20, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Milestone Payment, Phase 2/3 Study, Sunfish, Rg7916, Pediatric, Adult Patients, Type 2/3 Spinal Muscular Atrophy, Sma
